Welcome to BioTalk!

General 1 min
October 30, 2019

BioTalk, is the new hub brought to you by Bird & Bird’s International Life Sciences and Healthcare Group.

At Bird & Bird, we are passionate about Life sciences and Healthcare. We are delighted to launch our BioTalk online, so that we can bring you up to date news from across the Life sciences and Healthcare world, all in a more accessible and searchable way.

In BioTalk we will further inform you about legal and industry related news, in a user-friendly and dynamic way, proposing pragmatic advice and commentary by our experts and highlighting the important cases as well as the significant changes in law.

It features contributions of our renowned Life Sciences and Healthcare team composed by IP, Regulatory, Commercial, Corporate, Privacy and Competition specialists across Europe, Asia-Pacific and the Middle-East.

We hope you will appreciate our new format and should you want to be in touch with our editorial team, or would like to have further information about Bird & Bird’s International Life Sciences and Healthcare Group, please do not hesitate to contact us [here].

Written by
Marc Martens
Marc Martens
About me As co-head of our International Life Sciences & Healthcare group and head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels, I provide cutting edge strategic and regulatory advice to our life sciences clients and represent them in litigation.
Mark Hilton
Mark Hilton
I am a partner in our international Intellectual Property Group and co-head of our International Life Sciences & Healthcare Group. I'm based in London. As a partner in our Intellectual Property Group, I specialise in patent litigation and advise in the area of pharmaceuticals, biosimilars, biotechnology (including in food), chemicals and medical devices. However, my interests and experience also extend to a diverse range of technical fields including the financial services sector.

Related articles

China Health and Medical Data Protection (I): Human Genetic Resources Information
I. An Overview of Regulatory Regime Under the Chinese law, human generic resources...
Managing Scientific Collaboration Agreements within the French Healthtech Sector
Scientific Collaboration Agreements allow a public servant, most of the time a researcher, (who...
Final(ly) Rules of Procedure of the UPC
Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations,...
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.